2m 2m 2m 2m 2m 2m 2m
Madrigal Pharmct (MDGL)
NASDAQ
$533.00+$2.00 (+0.38%)
Price as of Jul 13, 2026 6:18 PM EDT- $12.4BMarket Cap
- 66.00%1-Year Change
- BiotechnologyIndustry
Madrigal Pharmct (MDGL)
$533.00+$2.00 (+0.38%)
MDGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $531.00 | ||
Change | -$5.70 (-1.06%) | ||
Open | $534.05 | ||
High | $539.15 | ||
Low | $526.14 | ||
Previous Close | $536.70 | ||
Volume | 287,887 | ||
30-Day Average Volume | 448,455 | ||
1-Week Change | 0.29% | ||
1-Month Change | 10.45% | ||
1-Year Change | 66.00% | ||
3-Year Change | 136.47% | ||
5-Year Change | 426.00% | ||
Fundamentals | |||
Shares Outstanding | 23.1M | ||
Total Assets | $1.2B | ||
Market Cap | $12.4B | ||
Enterprise Value | $12.5B | ||
Period: QTR TTM FY | |||
Revenue | $311.3M | ||
Net Income | -$94.4M | ||
Free Cash Flow | -$171.3M | ||
EBIT | -$94.4M | ||
EBITDA | -$94.0M | ||
Net Working Capital | $844.0M | ||
EPS | -$3.25 | ||
Enterprise Value/EBITDA | -133 | ||
Enterprise Value/Revenue | 40 | ||
P/B | 23 | ||
P/E | -165 | ||
PEG | 6 | ||
Price/Free Cash Flow | -72 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 07/25/2016 | ||
Earnings & Revenue